DFO
ALNY icon

Duquesne Family Office’s Alnylam Pharmaceuticals ALNY Stock Holding History

Duquesne Family Office’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-88,910
Closed -$21.1M – 49
2022
Q4 		$21.1M Hold
88,910
– – 1.05% 20
2022
Q3 		$17.8M Buy
+88,910
New +$17M 1.02% 25
2022
Q2 		– Sell
-63,945
Closed -$10.4M – 44
2022
Q1 		$10.4M Buy
+63,945
New +$9.74M 0.48% 27
2020
Q4 		– Sell
-368,419
Closed -$53.6M – 57
2020
Q3 		$53.6M Hold
368,419
– – 1.57% 18
2020
Q2 		$54.6M Hold
368,419
– – 1.67% 19
2020
Q1 		$40.1M Buy
368,419
+252,250
+217% +$29.1M 1.63% 17
2019
Q4 		$13.4M Buy
+116,169
New +$11.6M 0.41% 40

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return